Tandem Diabetes Care Inc. [NASDAQ: TNDM] surged by $5.32 during the normal trading session on Wednesday and reaching a high of $89.53 during the day while it closed the day at $86.71. Tandem Diabetes Care Inc. stock has also gained 7.51% of its value over the past 7 days. However, TNDM stock has inclined by 83.05% in the 3 months of the year. Over the past six months meanwhile, it has gained 42.83% and gained 45.46% year-on date.
The market cap for TNDM stock reached $5.12 billion, with 59.74 million shares outstanding and 57.03 million shares in the current float. Compared to the average trading volume of 1.18M shares, TNDM reached a trading volume of 3137102 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Here’s what leading stock market gurus have to say about Tandem Diabetes Care Inc. [TNDM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNDM shares is $90.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNDM stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
SVB Leerink have made an estimate for Tandem Diabetes Care Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on April 24, 2020. The new note on the price target was released on March 23, 2020, representing the official price target for Tandem Diabetes Care Inc. stock. Previously, the target price had yet another raise to $89, while Citigroup analysts kept a Neutral rating on TNDM stock.
The Average True Range (ATR) for Tandem Diabetes Care Inc. is set at 4.68, with the Price to Sales ratio for TNDM stock in the period of the last 12 months amounting to 12.98. The Price to Book ratio for the last quarter was 24.99, with the Price to Cash per share for the same quarter was set at 2.72. Price to Free Cash Flow for TNDM in the course of the last twelve months was 10231.78 with Quick ratio for the last quarter at 2.20.
TNDM stock trade performance evaluation
Tandem Diabetes Care Inc. [TNDM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.51. With this latest performance, TNDM shares gained by 2.82% in over the last four-week period, additionally plugging by 42.83% over the last 6 months – not to mention a rise of 34.10% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNDM stock in for the last two-week period is set at 59.50, with the RSI for the last a single of trading hit 63.60, and the three-weeks RSI is set at 57.34 for Tandem Diabetes Care Inc. [TNDM]. The present Moving Average for the last 50 days of trading for this stock 79.43, while it was recorded at 82.16 for the last single week of trading, and 68.92 for the last 200 days.
Tandem Diabetes Care Inc. [TNDM]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Tandem Diabetes Care Inc. [TNDM] shares currently have an operating margin of -4.62 and a Gross Margin at +52.01. Tandem Diabetes Care Inc.’s Net Margin is presently recorded at -6.83.
Return on Total Capital for TNDM is now -9.65, given the latest momentum, and Return on Invested Capital for the company is -14.55. Return on Equity for this stock declined to -15.17, with Return on Assets sitting at -9.30. When it comes to the capital structure of this company, Tandem Diabetes Care Inc. [TNDM] has a Total Debt to Total Equity ratio set at 10.45. Additionally, TNDM Total Debt to Total Capital is recorded at 9.46, with Total Debt to Total Assets ending up at 6.25. Long-Term Debt to Equity for the company is recorded at 7.21, with the Long-Term Debt to Total Capital now at 6.53.
Reflecting on the efficiency of the workforce at the company, Tandem Diabetes Care Inc. [TNDM] managed to generate an average of -$23,733 per employee. Receivables Turnover for the company is 8.86 with a Total Asset Turnover recorded at a value of 1.36.Tandem Diabetes Care Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.20 and a Current Ratio set at 2.80.
Earnings per share (EPS) analysis for Tandem Diabetes Care Inc. [TNDM] stock
With the latest financial reports released by the company, Tandem Diabetes Care Inc. posted -0.03/share EPS, while the average EPS was predicted by analysts to be reported at -0.25/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 88.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TNDM.
Tandem Diabetes Care Inc. [TNDM]: Insider Ownership positions
There are presently around $4,693 million, or 94.70% of TNDM stock, in the hands of institutional investors. The top three institutional holders of TNDM stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 6,788,022, which is approximately 122.894% of the company’s market cap and around 4.39% of the total institutional ownership; FMR LLC, holding 5,565,473 shares of the stock with an approximate value of $452.97 million in TNDM stocks shares; and VANGUARD GROUP INC, currently with $430.82 million in TNDM stock with ownership of nearly -3.502% of the company’s market capitalization.
Positions in Tandem Diabetes Care Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 138 institutional holders increased their position in Tandem Diabetes Care Inc. [NASDAQ:TNDM] by around 13,806,370 shares. Additionally, 160 investors decreased positions by around 9,127,204 shares, while 36 investors held positions by with 34,726,999 shares. The mentioned changes placed institutional holdings at 57,660,573 shares, according to the latest SEC report filing. TNDM stock had 55 new institutional investments in for a total of 2,508,563 shares, while 54 institutional investors sold positions of 3,831,349 shares during the same period.